Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    Global Pharmaceutical Automation Market size was valued at USD 8.38 Billion in 2024 and is poised to grow from USD 9.29 Billion in 2025 to USD 21.09 Billion by 2033, growing at a CAGR of 10.8% during the forecast period (2026–2033). 

    'Becton, Dickinson and Company (USA) ', 'Baxter International Inc. (USA) ', 'Siemens Healthineers (Germany) ', 'GE Healthcare (USA) ', 'Omnicell, Inc. (USA) ', 'Swisslog Healthcare (Switzerland) ', 'Capsa Healthcare (USA) ', 'Parata Systems (USA) ', 'ARxIUM (Canada) ', 'ScriptPro LLC (USA) ', 'Yuyama Co., Ltd. (Japan) ', 'McKesson Corporation (USA) ', 'Pearson Medical Technologies (USA) ', 'Accu-Chart Plus Healthcare Systems (USA) ', 'NewIcon (Finland) ', 'AlixaRx (USA) ', 'KUKA AG (Germany) ', 'TOSHO Inc. (Japan) ', 'Cerner Corporation (USA)'

    The rising use of robots in pharmaceutical manufacturing, government programmes to support industrial development, rising investments in modernising traditional production facilities, and rising consumer demand for secure and digitalized production processes are all factors contributing to the growth of this market.

    The rising need for equipment that lowers pharmaceutical mistakes is fueling the expansion of the worldwide pharmacy automation market.

    On the basis of region, it is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa (MEA). The pharmaceutical automation market is anticipated to be dominated by Asia-Pacific in 2022, followed by Europe and North America. The significant market share held by Asia-Pacific is attributable to China, Japan, and Singapore's high levels of technical robotics awareness. The Asia-Pacific market for pharmaceutical automation solutions is driven in part by the region's strong pharmaceutical manufacturing sector. North America dominated the market and took home the largest percentage of revenue, amounting to more than 54.5%. Among the main forces behind the region's growth are the region's advanced healthcare system, improvements in patient management, and hospital management systems. According to a report in Drug Store News, automation and other forms of technology have been more prevalent over the past 15 months for both prescribers and pharmacists, with 66% of prescribers reporting this. The COVID-19 pandemic has fueled the growth of technology adoption, according to many technology vendors, who also claim that pharmacy automation is the future.

    Feedback From Our Clients

    Global Pharmaceutical Automation Market

    Report ID: SQMIG35A2186

    $5,300
    BUY NOW GET FREE SAMPLE